Currently, there is no known specific medicine to treat the novel coronavirus, but researchers in Italy suggest that the COVID-19 disease is slow to mutate, based on its genetic material. The study, which was produced by two independent teams in the country, used “a new next-generation sequencing (NGS) research assay” from Thermo Fisher Scientific on Italian COVID-19 patients. The experts then compared them to a sample from the original outbreak to come up with their findings.
